Adoption of vaginally assisted natural orifice transluminal endoscopic surgery for hysterectomy: A single tertiary experience

Abstract

BackgroundVaginal hysterectomy (VH) rate is declining despite being considered as the optimal minimally invasive option for hysterectomy with reduced operative time and length of stay compared with laparoscopic hysterectomy (LH). Vaginal assisted natural orifice transluminal endoscopic surgery hysterectomy (VANH) combines the advantages of both vaginal and endoscopic approach to surgery.AimsTo report feasibility and early experience of a single surgeon adopting VANH at a tertiary Australian hospital.Materials and MethodsProspective review of the first 20 VANH cases with complete data set collected retrospectively including patient demographics, indication for surgery and perioperative outcomes.ResultsThe median age of the first 20 participants was 51.5 years (47–57 years of age) and the median body mass index was 33.5 kg/m2 (27.8–38.3 kg/m2). The predominant indication was complex hyperplasia with atypia (12/20, 60%). The median parity was two (1–3) where four patients were nulliparous. The median blood loss was 125 mL (100–200 mL) with an operative time of 149 min (138–198 min) and median weight of the specimen of 181.5 g (66.5–219 g). The mean length of stay was 1.4 days (1–2 days). Five cases had conversion to laparoscopy and the majority (80%) occurred within the first ten cases.ConclusionsVANH is feasible but there is a learning curve to achieve competence in this technique, which requires adequate training in the early stages of adoption with careful case selection. Until further robust data is available to determine the clinical benefit and safety profile of VANH, patients should be carefully counselled and the decision on mode of hysterectomy be individualised.